Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire.

Guerder S, Hassel C, Carrier A.

Immunogenetics. 2019 Mar;71(3):223-232. doi: 10.1007/s00251-018-1078-y. Epub 2018 Sep 17. Review.

PMID:
30225612
2.

Thymic-Specific Serine Protease Limits Central Tolerance and Exacerbates Experimental Autoimmune Encephalomyelitis.

Serre L, Girard M, Ramadan A, Menut P, Rouquié N, Lucca LE, Mahiddine K, Leobon B, Mars LT, Guerder S.

J Immunol. 2017 Dec 1;199(11):3748-3756. doi: 10.4049/jimmunol.1700667. Epub 2017 Oct 23.

3.

The site of tumor development determines immunogenicity via temporal mobilization of antigen-laden dendritic cells in draining lymph nodes.

Joncker NT, Bettini S, Boulet D, Guiraud M, Guerder S.

Eur J Immunol. 2016 Mar;46(3):609-18. doi: 10.1002/eji.201545797. Epub 2015 Dec 22.

4.

The T Cell Repertoire-Diversifying Enzyme TSSP Contributes to Thymic Selection of Diabetogenic CD4 T Cell Specificities Reactive to ChgA and IAPP Autoantigens.

Viret C, Mahiddine K, Baker RL, Haskins K, Guerder S.

J Immunol. 2015 Sep 1;195(5):1964-73. doi: 10.4049/jimmunol.1401683. Epub 2015 Jul 24.

5.

Central tolerance spares the private high-avidity CD4(+) T-cell repertoire specific for an islet antigen in NOD mice.

Serre L, Fazilleau N, Guerder S.

Eur J Immunol. 2015 Jul;45(7):1946-56. doi: 10.1002/eji.201445290. Epub 2015 May 12.

6.

Dendritic cells in tolerance and autoimmune diabetes.

Guerder S, Joncker N, Mahiddine K, Serre L.

Curr Opin Immunol. 2013 Dec;25(6):670-5. doi: 10.1016/j.coi.2013.10.004. Epub 2013 Oct 26. Review.

PMID:
24168964
7.

Retroviral transduction of lineage antigen-negative ((Lin−) cells: a valuable alternative for the generation of T cell receptor (TCR) retrogenic mice.

Viret C, Cresson C, Broccardo C, Guerder S.

J Immunol Methods. 2012 Oct 31;384(1-2):103-10. doi: 10.1016/j.jim.2012.07.014. Epub 2012 Jul 31.

PMID:
22867746
8.

Differential processing of self-antigens by subsets of thymic stromal cells.

Guerder S, Viret C, Luche H, Ardouin L, Malissen B.

Curr Opin Immunol. 2012 Feb;24(1):99-104. doi: 10.1016/j.coi.2012.01.008. Epub 2012 Jan 30. Review.

PMID:
22296716
9.

Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice.

Viret C, Leung-Theung-Long S, Serre L, Lamare C, Vignali DA, Malissen B, Carrier A, Guerder S.

J Clin Invest. 2011 May;121(5):1810-21. doi: 10.1172/JCI43314. Epub 2011 Apr 18.

10.

Thymus-specific serine protease contributes to the diversification of the functional endogenous CD4 T cell receptor repertoire.

Viret C, Lamare C, Guiraud M, Fazilleau N, Bour A, Malissen B, Carrier A, Guerder S.

J Exp Med. 2011 Jan 17;208(1):3-11. doi: 10.1084/jem.20100027. Epub 2010 Dec 20.

11.

Impaired NFAT transcriptional activity in antigen-stimulated CD8 T cells linked to defective phosphorylation of NFAT transactivation domain.

Leung-Theung-Long S, Mondor I, Guiraud M, Lamare C, Nagaleekar V, Paulet PE, Rincon M, Guerder S.

J Immunol. 2009 Jun 1;182(11):6807-14. doi: 10.4049/jimmunol.0803539. Erratum in: J Immunol. 2009 Aug 1;183(3):2194. Nageleekar, Viswas [corrected to Nagaleekar, Viswas].

12.

Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes.

Gommeaux J, Grégoire C, Nguessan P, Richelme M, Malissen M, Guerder S, Malissen B, Carrier A.

Eur J Immunol. 2009 Apr;39(4):956-64. doi: 10.1002/eji.200839175.

13.

[Th17 cells, a novel proinflammatory effector CD4 T cell population].

Leung-Theung-Long S, Guerder S.

Med Sci (Paris). 2008 Nov;24(11):972-6. doi: 10.1051/medsci/20082411972. French.

14.

CD86 has sustained costimulatory effects on CD8 T cells.

Thomas IJ, Petrich de Marquesini LG, Ravanan R, Smith RM, Guerder S, Flavell RA, Wraith DC, Wen L, Wong FS.

J Immunol. 2007 Nov 1;179(9):5936-46.

15.

RelA regulates the survival of activated effector CD8 T cells.

Mondor I, Schmitt-Verhulst AM, Guerder S.

Cell Death Differ. 2005 Nov;12(11):1398-406.

16.
17.

Homing to nonlymphoid tissues is not necessary for effector Th1 cell differentiation.

Bajénoff M, Guerder S.

J Immunol. 2003 Dec 15;171(12):6355-62.

19.

TNF-alpha impairs peripheral tolerance towards beta-cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells.

Skak K, Guerder S, Picarella DE, Brenden N, Flavell RA, Michelsen BK.

Eur J Immunol. 2003 May;33(5):1341-50.

20.

A novel reporter strain to follow Cre-mediated recombination in T and NK cells.

Wurtz O, Pophillat M, Schmitt-Verhulst AM, Guerder S.

Genesis. 2002 Apr;32(4):287-92.

PMID:
11948916
21.
22.

[Dendritic cells and interaction with other cell types. Immune tolerance].

Guerder S.

Pathol Biol (Paris). 2001 Jul;49(6):473-4. Review. French.

PMID:
11484607
23.

Regulation of activator protein-1 and NF-kappa B in CD8+ T cells exposed to peripheral self-antigens.

Guerder S, Rincòn M, Schmitt-Verhulst AM.

J Immunol. 2001 Apr 1;166(7):4399-407.

24.

Selection of phenotypically distinct NK1.1+ T cells upon antigen expression in the thymus or in the liver.

Legendre V, Boyer C, Guerder S, Arnold B, Hämmerling G, Schmitt-Verhulst AM.

Eur J Immunol. 1999 Jul;29(7):2330-43.

25.

Targeted expression of calcitonin gene-related peptide to osteoblasts increases bone density in mice.

Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, Gundberg C, Gilligan J, Flavell RA, Vignery A.

J Bone Miner Res. 1999 Jul;14(7):1067-74.

27.

Targeted expression of the neuropeptide calcitonin gene-related peptide to beta cells prevents diabetes in NOD mice.

Khachatryan A, Guerder S, Palluault F, Cote G, Solimena M, Valentijn K, Millet I, Flavell RA, Vignery A.

J Immunol. 1997 Feb 1;158(3):1409-16.

PMID:
9013986
28.

Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1.

Coulombe M, Yang H, Guerder S, Flavell RA, Lafferty KJ, Gill RG.

J Immunol. 1996 Dec 1;157(11):4790-5.

PMID:
8943380
29.

Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.

Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA.

Immunity. 1996 Feb;4(2):167-78.

30.
31.

B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors.

Guerder S, Carding SR, Flavell RA.

J Immunol. 1995 Dec 1;155(11):5167-74.

PMID:
7594526
32.

T-cell activation. Two for T.

Guerder S, Flavell RA.

Curr Biol. 1995 Aug 1;5(8):866-8. Review.

33.

Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse.

Wong S, Guerder S, Visintin I, Reich EP, Swenson KE, Flavell RA, Janeway CA Jr.

Diabetes. 1995 Mar;44(3):326-9.

PMID:
7533734
34.

Costimulation in tolerance and autoimmunity.

Guerder S, Flavell RA.

Int Rev Immunol. 1995;13(2):135-46. Review.

PMID:
8789426
35.
36.
37.

A fail-safe mechanism for maintaining self-tolerance.

Guerder S, Matzinger P.

J Exp Med. 1992 Aug 1;176(2):553-64.

38.

Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma.

Vidović D, Roglić M, McKune K, Guerder S, MacKay C, Dembić Z.

Nature. 1989 Aug 24;340(6235):646-50.

PMID:
2528072
39.

Does T-cell tolerance require a dedicated antigen-presenting cell?

Matzinger P, Guerder S.

Nature. 1989 Mar 2;338(6210):74-6.

PMID:
2783992
40.

Activation versus tolerance: a decision made by T helper cells.

Guerder S, Matzinger P.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:799-805. No abstract available.

PMID:
2534844

Supplemental Content

Loading ...
Support Center